Phase II trial of PTK787/ZK222584 [vatalanib] in patients with advanced or metastatic pancreatic adenocarcinoma who failed first-line gemcitabine therapy.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2014
At a glance
- Drugs Vatalanib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 04 Apr 2008 Status change
- 22 Oct 2005 New trial record.